Cannabis and Cannabinoid Research

Papers
(The H4-Index of Cannabis and Cannabinoid Research is 24. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
Kinetics of CBD, Δ 9 -THC Degradation and Cannabinol Formation in Cannabis Resin at Various Temperature and pH Conditions97
Brain Penetrant, but not Peripherally Restricted, Synthetic Cannabinoid 1 Receptor Agonists Promote Morphine-Mediated Respiratory Depression63
Increased White Matter Coherence Following Three and Six Months of Medical Cannabis Treatment59
The Endocannabinoid System as a Potential Therapeutic Target for HIV-1-Associated Neurocognitive Disorder57
Understanding and Rebalancing: A Rapid Scoping Review of Cannabis Research Among Indigenous People54
Case in Context: Acne Inversa (Hidradenitis Suppurativa)53
A Double-Blind, Randomized, Placebo-Controlled Test of the Effects of Cannabidiol on Experiences of Test Anxiety Among College Students47
Cannabidiol Marketing Strategies in the United States: An Analysis of Three Prominent Companies40
Stakeholders' Decisions and Preferences for the Provision and Use of Medicinal Cannabis: A Scoping Review40
Endocannabinoid System Biomarkers in Alzheimer's Disease36
The Utility of THC Cutoff Levels in Blood and Saliva for Detection of Impaired Driving35
Pharmacokinetics of Oral Minor Cannabinoids in Blood and Brain35
Typical Hits, Grams, or Joints: Evaluating Cannabis Survey Measurement Strategies for Quantifying Consumption34
Intra-Accumbal D1- But not D2-Like Dopamine Receptor Antagonism Reverses the Inhibitory Effects of Cannabidiol on Extinction and Reinstatement of Methamphetamine Seeking Behavior in Rats34
A Preliminary Pharmacokinetic Comparison of Δ-9 Tetrahydrocannabinol and Cannabidiol Extract Versus Oromucosal Spray in Healthy Men and Women33
Comparative Pharmacokinetic Assessment of Innovative Sublingual, Rectal and Vaporizer Cannabis Products Versus Approved Cannabis Products in Healthy Volunteers33
Legalization of Smokable Medical Cannabis and Changes in the Dispensed Amount of Δ-9 Tetrahydrocannabinol Per Patient32
Cannabis Use and Biomarkers of Inflammation, Immune Activation, and Microbial Translocation in Persons with HIV31
Acknowledgment of Reviewers 202529
Acknowledgment of Reviewers 202429
Medical Cannabis for the Treatment of Peripheral Neuropathy due to Diabetes: A Systematic Review29
Letter to the Editor: Response to Dr. Mousavi’s Comments on Ogunsola et al28
A Scoping Review on the Medical and Recreational Use of Cannabis During the COVID-19 Pandemic27
An Updated Analysis of Clinical Outcome Measures Across Patients From the UK Medical Cannabis Registry24
Genome-Wide Identification and Expression Profiles of bZIP Genes in Cannabis sativa L.24
0.11718511581421